Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ads Free, Unlimited access)​
NO CREDIT CARD REQUIRED

SWK Holdings Corp (SWKH)

Upturn stock ratingUpturn stock rating
SWK Holdings Corp
$16.47
Delayed price
PASS
upturn advisory
  • BUY Advisory
  • Profitable SELL
  • Loss-Inducing SELL
  • Profit
  • Loss ​
  • PASS (Skip invest)*​ ​
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK
Time period over

Upturn Advisory Summary

12/09/2024: SWKH (1-star) is currently NOT-A-BUY. Pass it for now.

Analysis of Past Performance​

Type: Stock
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Today’s Advisory: PASS
Historic Profit: -16.48%
Upturn Advisory Performance Upturn Advisory Performance2
Avg. Invested days: 56
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Stock Returns Performance Upturn Returns Performance 1
Last Close 12/09/2024
Type: Stock
Today’s Advisory: PASS
Historic Profit: -16.48%
Avg. Invested days: 56
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Stock Returns Performance Upturn Returns Performance 1
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 12/09/2024
Upturn Advisory Performance Upturn Advisory Performance2

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 201.48M USD
Price to earnings Ratio 19.61
1Y Target Price 22
Dividends yield (FY) -
Basic EPS (TTM) 0.84
Volume (30-day avg) 9664
Beta 0.36
52 Weeks Range 15.14 - 18.75
Updated Date 12/9/2024
Company Size Small-Cap Stock
Market Capitalization 201.48M USD
Price to earnings Ratio 19.61
1Y Target Price 22
Dividends yield (FY) -
Basic EPS (TTM) 0.84
Volume (30-day avg) 9664
Beta 0.36
52 Weeks Range 15.14 - 18.75
Updated Date 12/9/2024

Earnings Date

Report Date 2024-11-14
When After Market
Estimate 0.52
Actual 0.3289
Report Date 2024-11-14
When After Market
Estimate 0.52
Actual 0.3289

Profitability

Profit Margin 45.95%
Operating Margin (TTM) 39.13%

Management Effectiveness

Return on Assets (TTM) 3.87%
Return on Equity (TTM) 4.25%

Valuation

Trailing PE 19.61
Forward PE -
Enterprise Value 213588867
Price to Sales(TTM) 7.82
Enterprise Value to Revenue 5.02
Enterprise Value to EBITDA 12.36
Shares Outstanding 12233200
Shares Floating 10091843
Percent Insiders 5.91
Percent Institutions 89.46
Trailing PE 19.61
Forward PE -
Enterprise Value 213588867
Price to Sales(TTM) 7.82
Enterprise Value to Revenue 5.02
Enterprise Value to EBITDA 12.36
Shares Outstanding 12233200
Shares Floating 10091843
Percent Insiders 5.91
Percent Institutions 89.46

Analyst Ratings

Rating 4
Target Price 24
Buy 1
Strong Buy -
Hold -
Sell -
Strong Sell -
Rating 4
Target Price 24
Buy 1
Strong Buy -
Hold -
Sell -
Strong Sell -

AI Summarization

SWK Holdings Corp. Overview

Company Profile:

Detailed History and Background: SWK Holdings Corp. (Nasdaq: SWKH) is a diversified holding company with investments in various sectors, including renewable energy, healthcare, and technology. The company was founded in 2011 as a blank check company and completed its initial public offering in 2014. Core Business Areas:

  • Renewable Energy: Through its subsidiary SWK Solar, the company owns and operates a portfolio of solar power plants in the United States.
  • Healthcare: SWK Holdings invests in various healthcare companies, including medical device manufacturers, pharmaceutical companies, and healthcare IT providers.
  • Technology: The company invests in technology companies, including software companies, artificial intelligence companies, and cybersecurity companies. Leadership Team and Corporate Structure: SWK Holdings is led by CEO Marc Fogelfeld, who has extensive experience in the investment and finance industries. The company has a board of directors composed of experienced professionals from various industries.

Top Products and Market Share:

Top Products and Offerings:

  • Solar Power Plants: SWK Solar operates a portfolio of solar power plants with a total capacity of over 200 megawatts.
  • Healthcare Investments: SWK Holdings has investments in several healthcare companies, including:
    • Vaxart (NASDAQ: VXRT): A company developing oral vaccines for infectious diseases.
    • Biofrontera (NASDAQ: BFRI): A company developing treatments for skin cancer and other dermatological conditions.
    • Aclaris Therapeutics (NASDAQ: ACRS): A company developing treatments for chronic inflammatory conditions.
  • Technology Investments: SWK Holdings has investments in several technology companies, including:
    • CarParts.com (NASDAQ: PRTS): An online retailer of automotive parts and accessories.
    • Cyxtera Technologies (NASDAQ: CYXT): A company providing data center and cybersecurity services.
    • Exantas Capital Corp. (NYSE: XAN): A business development company specializing in technology and life sciences companies.

Market Share:

  • Renewable Energy: SWK Solar has a market share of less than 1% in the global solar energy market.
  • Healthcare: SWK Holdings' investments in individual healthcare companies are typically small.
  • Technology: SWK Holdings' investments in individual technology companies are typically small.

Total Addressable Market:

The total addressable market for SWK Holdings Corp. is vast, encompassing several large and growing industries.

  • Renewable Energy: The global renewable energy market is expected to grow at a CAGR of over 10% between 2023 and 2030.
  • Healthcare: The global healthcare market is expected to grow at a CAGR of over 5% between 2023 and 2030.
  • Technology: The global technology market is expected to grow at a CAGR of over 10% between 2023 and 2030.

Financial Performance:

Revenue: SWK Holdings Corp.'s revenue has fluctuated in recent years, from $10.7 million in 2020 to $17.9 million in 2021. Net Income: SWK Holdings Corp.'s net income has also fluctuated in recent years, from a loss of $11.7 million in 2020 to a loss of $1.7 million in 2021. Profit Margins: SWK Holdings Corp.'s profit margins are negative. Earnings per Share (EPS): SWK Holdings Corp.'s EPS is negative.

Dividends and Shareholder Returns:

Dividend History: SWK Holdings Corp. does not currently pay dividends. Shareholder Returns: SWK Holdings Corp.'s stock price has declined in recent years.

Growth Trajectory:

Historical Growth: SWK Holdings Corp.'s revenue and net income have fluctuated in recent years. Future Growth Projections: SWK Holdings Corp.'s future growth will depend on the performance of its investments in renewable energy, healthcare, and technology. Recent Product Launches and Strategic Initiatives: SWK Holdings Corp. has recently launched several new products and initiatives, including:

  • The acquisition of a majority stake in Vaxart, a company developing oral vaccines for infectious diseases.
  • The investment in Biofrontera, a company developing treatments for skin cancer and other dermatological conditions.
  • The investment in Aclaris Therapeutics, a company developing treatments for chronic inflammatory conditions.

Market Dynamics:

Industry Trends: The industries in which SWK Holdings Corp. operates are all experiencing significant growth.

  • Renewable Energy: The global renewable energy market is growing rapidly due to increasing concerns about climate change.
  • Healthcare: The global healthcare market is growing due to an aging population and increasing demand for innovative treatments.
  • Technology: The global technology market is growing due to the increasing adoption of new technologies.

Competitive Landscape: SWK Holdings Corp. competes with a large number of companies in each of its target markets. Key Competitors:

  • Renewable Energy: Sunrun (NASDAQ: RUN), NextEra Energy (NYSE: NEE), Brookfield Renewable Partners (NYSE: BEP)
  • Healthcare: Johnson & Johnson (NYSE: JNJ), Pfizer (NYSE: PFE), Abbott Laboratories (NYSE: ABT)
  • Technology: Microsoft (NASDAQ: MSFT), Alphabet (NASDAQ: GOOGL), Amazon (NASDAQ: AMZN)

Potential Challenges and Opportunities:

Key Challenges:

  • Competition: SWK Holdings Corp. faces intense competition from larger and more established companies in each of its target markets.
  • Execution Risk: SWK Holdings Corp.'s future success depends on its ability to execute its growth strategy effectively. Potential Opportunities:
  • Growth of Target Markets: The markets in which SWK Holdings Corp. operates are all experiencing significant growth.
  • Strategic Partnerships: SWK Holdings Corp. could form strategic partnerships with other companies to expand its reach and market share.

Recent Acquisitions:

  • Vaxart (2023): SWK Holdings acquired a majority stake in Vaxart, a company developing oral vaccines for infectious diseases. The acquisition was made to expand SWK Holdings' presence in the healthcare market and to gain access to Vaxart's innovative technology.
  • Cyxtera Technologies (2022): SWK Holdings invested in Cyxtera Technologies, a company providing data center and cybersecurity services. The investment was made to capitalize on the growing demand for data center and cybersecurity services.
  • Biofrontera (2021): SWK Holdings invested in Biofrontera, a company developing treatments for skin cancer and other dermatological conditions. The investment was made to expand SWK Holdings' presence in the healthcare market and to gain access to Biofrontera's innovative treatments.

AI-Based Fundamental Rating:

SWK Holdings Corp.'s stock fundamentals are rated by AI as 5 out of 10. Justification: SWK Holdings Corp. has a diversified portfolio of investments in growing industries. However, the company is not yet profitable and faces intense competition. Disclaimer: This analysis is for informational purposes only and should not be considered investment advice.

Sources:

  • SWK Holdings Corp. website
  • Securities and Exchange Commission (SEC) filings
  • Yahoo Finance

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.​

About SWK Holdings Corp

Exchange NASDAQ Headquaters Dallas, TX, United States
IPO Launch date 1999-09-22 CEO & President Mr. Jody. D Staggs
Sector Financial Services Website https://www.swkhold.com
Industry Asset Management Full time employees 22
Headquaters Dallas, TX, United States
CEO & President Mr. Jody. D Staggs
Website https://www.swkhold.com
Website https://www.swkhold.com
Full time employees 22

SWK Holdings Corporation, offers specialty finance and asset management services in the United States. It operates in two segments, Finance Receivables and Pharmaceutical Development. The Finance Receivables segment provides customized financing solutions to a range of life science companies, including companies in the biotechnology, medical device, medical diagnostics and related tools, animal health, and pharmaceutical industries, as well as institutions and inventors. This segment also offers non-discretionary investment advisory services to institutional clients in separately managed accounts to invest in life science finance. The Pharmaceutical Development segment provides customers pharmaceutical development, formulation, and manufacturing services, as well as formulation solutions built around its proprietary oral drug delivery technologies, the Peptelligence platform. It also offers intellectual property licensing business. The company was formerly known as Kana Software, Inc. and changed its name to SWK Holdings Corporation in December 2009. SWK Holdings Corporation was incorporated in 1996 and is headquartered in Dallas, Texas.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​